APA

Colquhoun A. J., Mchugh L. A., Tulchinsky E., Kriajevska M. & Mellon J. K. (20071206). Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. : Journal of radiation research.

Chicago

Colquhoun A J, Mchugh L A, Tulchinsky E, Kriajevska M and Mellon J K. 20071206. Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. : Journal of radiation research.

Harvard

Colquhoun A. J., Mchugh L. A., Tulchinsky E., Kriajevska M. and Mellon J. K. (20071206). Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. : Journal of radiation research.

MLA

Colquhoun A J, Mchugh L A, Tulchinsky E, Kriajevska M and Mellon J K. Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. : Journal of radiation research. 20071206.